期刊文献+

比索洛尔对陈旧性心肌梗死病人心功能的影响 被引量:1

Effect of Bisoprolol on Heart Function in Old Myocardial Infarction
暂未订购
导出
摘要 为探讨 β1 受体阻滞剂比索洛尔对陈旧性心肌梗死 (OMI)患者心功能的影响 ,观察了 35例心功能Ⅱ~Ⅲ级OMI患者在服用比索洛尔 ( 2 .5mg/d)前及用药后 1~ 2月末的心率、血压和多普勒超声参数变化。用药后 ,血压由用药前 ( 2 0 .0 8/ 1 0 .64± 3.33/ 2 .2 6)kPa降至 ( 1 9.4 2 / 1 0 .37± 2 .79/ 1 .86)kPa(P <0 .0 1 ) ,心率由用药前 ( 70 .66±1 2 .86)次 /min降至 ( 64.31± 9.84 )次 /min(P <0 .0 1 ) ,反映左室舒张功能的多普勒超声参数E/A显著增加〔用药前0 .85± 0 .1 8,用药后 1 .1 4± 0 .35(P <0 .0 1 )〕 ,而收缩功能指标每搏输出量 (SV)、心排出量 (CO)、射血分数 (EF)和短轴缩短率 (FS)的变化不明显。因此较小剂量的比索洛尔即可明显降低OMI患者的血压和心率 。 To investigate the effects of bisoprolol on heart function in old myocardial infarction(OMI), 35 patients with OMI received bisoprolol 2.5 mg per day for two months. Doppler echocardiographic measurements of left ventricular structure, transmitral flow velocity pattern, blood pressure and heart rate were monitored before and after 1 and 2 months therapy. Bisoprolol led to reduction in blood pressure and heart rate 〔(20.08/10.64±3.33/2.26) vs (19.42/10.37±2.79/1.86) kPa P <0.01, (70.66±12.86) vs (64.31±9.84) bits/min P <0.01〕, and E/A increased significantly 〔(0.85±0.18) vs (1.14±0.35) P <0.01〕. No significant affection was found on left ventracular systolic function. Bisoprolol reduces blood pressure and heart rate, improves diastolic function, hence it would be valuable in treatment of OMI.
出处 《首都医科大学学报》 CAS 2001年第2期129-131,共3页 Journal of Capital Medical University
关键词 舒张功能 超声心动图 陈旧性心肌梗死 心功能 比索洛尔 myocardial infarction diastolic function echocardiography
  • 相关文献

参考文献13

  • 1[1]ISIS-1 Collaborative Group. Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction; ISIS-1. Lancet, 1986,2:7~66
  • 2[2]Aronow W S, Ahn C, Kronzon I. Effect of propranolol versus no propranlol on total mortality plus nonfatal mylcardial infarction in older patients with prior myocardial infarction, congestive heart failure, and left ventricular ejection fraction greater than or equal to 40% treated with diuretics plus angiotensin converting enzyme inhibitors. Am J Cardiol, 1997,90:20~29
  • 3[3]Kjekshus J, Gullestad L. Heart rate as a therapeutic target in heart failure. Eur Heart J, 1999, 1:64~69
  • 4[4]Held P H, Teo K K, Yusuf S, et al. Effects of beta-blockers, nitrates and magnesium in acute myocardial infarction and angina pectoris. In: Topol, ed. Textbook of Interventional Cardiology. Philadelphia: Saunders, 1993
  • 5[5]Bristow M R. Differences in beta-adre-nergic neuroeffector mechanisms in ischemic versus idiopahic dilated cardiomyopathy. Circulation, 1991,84:1024~1031
  • 6[6]Henry K. Changes in plasma eadotheoin-1 levels reflect clinical response to β-blockeade in chronic heart failure. Am Heart J, 1996,131:337~342
  • 7[7]Maisel A S. Beneficial effects of metoprolol treatment in congestive heart failure. Reversal of sympathic induced alterations of immunologic function. Circulation, 1994,90:1774~1781
  • 8[8]Carson P E. Beta blocker treatment in heart fai-lure. Prog Cardiovasc Dis, 1999,41(4):301~321
  • 9[9]Eichorn E J. Our new understanding of heart fai-lure: The role of beta blockers in treatment. Cleve Clin J Med, 1998,65(8):428~435
  • 10[10]Andresen D, Ehlers H C, Wiedemann M, et al. Beta blocker: Evidence versus wishful thinking. Am J Cardiol, 1999,83(5):64~67

同被引文献1

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部